ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1242

Germ Line DNA Methylation Profiling Provides Novel Insights into the Parent-of-Origin Effect in Psoriatic Disease

Remy Pollock1, Darren O'Reilly2, Proton Rahman3, Vinod Chandran4 and Dafna Gladman4, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Memorial University of Newfoundland, St. John's, NF, Canada, 3Computer Sciences, Memorial University of Newfoundland, St. John's, NF, Canada, 4Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: DNA Methylation, Epigenetics, psoriasis and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Genetics, Genomics and Proteomics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Parent-of-origin effects refer to the differential risk or pathogenicity of a disease that depends on the sex of the disease-transmitting parent. Excessive paternal transmission has been described in psoriasis and psoriatic arthritis (PsA) patients. Genomic imprinting or other germ line epigenetic phenomena have been hypothesized to mediate this effect. This study aimed to investigate the presence of germ line epigenetic variants associated with psoriasis and PsA.

Methods: Male psoriasis (n=24) and PsA (n=13) patients were recruited from the University of Toronto Psoriatic Disease Program. Psoriasis patients were diagnosed by a dermatologist and examined by a rheumatologist to verify the absence of PsA. PsA patients were diagnosed by a rheumatologist and satisfied the CASPAR criteria. Unaffected male controls (n=19) with no family history of psoriasis or PsA were also recruited. Sperm cells were isolated from semen samples and genomic DNA was extracted and bisulfite converted. DNA methylation was measured at 485,577 CpG sites using Illumina HumanMethylation 450k arrays. Methylation differences were assessed by Student’s t-test using M-values and then converted to percent differences in methylation (β diff) between groups.

Results: Differential methylation analysis performed on 331,258 unique CpG sites retained after filtering identified 57 differentially methylated CpG sites between psoriasis patients and controls, and 97 between PsA patients and controls (p<0.05). Top hits in psoriasis patients vs. controls included CpG sites near the long non-coding RNA TINCR (β diff=0.14, p=0.03) and IRF6 (β diff=0.16, p=0.03), which are necessary for epidermal differentiation. Top CpG sites in PsA vs. controls were located near LCP1 (β diff=0.16, p=0.01), which regulates polarization and migration of chemokine-stimulated T lymphocytes, and PsA susceptibility locus HLA-B (β diff=-0.25, p=0.03) on 6p21.3. The inflammasome component NLRP13 was differentially methylated in both PsA (β diff=0.11, p=1.8×10-3) and psoriasis (β diff=0.09, p=7.6×10-3) patients compared to controls. There were 84 differentially methylated CpGs between PsA vs. psoriasis patients (p<0.05). Top CpGs were located near TPPP (β diff=0.25, p=1.4×10-4), involved in tubulin polymerization, and HCG26, a non-coding RNA that lies between MICA and MICB on 6p21.3 (β diff=-0.22, p=4.0×10-3). Upon combining the results of all three analyses, five hits mapped to a 2.1 Mb interval on chromosome 8p23.3 that we previously identified as differentially methylated in whole blood of PsA patients with paternally vs. maternally-transmitted disease. Hits in this region were located near the genes ERICH1-AS1, MYOM2, CSMD1, and DLGAP2, which has been computationally identified as a putative paternally imprinted gene.

Conclusion: We identified several differentially methylated CpG sites in the germ line of psoriasis and PsA patients. These preliminary results require further experimental verification and replication in somatic tissues, to determine their relevance to the parent-of-origin effect and the aetiopathogenesis of psoriasis and PsA.


Disclosure: R. Pollock, None; D. O'Reilly, None; P. Rahman, None; V. Chandran, None; D. Gladman, None.

To cite this abstract in AMA style:

Pollock R, O'Reilly D, Rahman P, Chandran V, Gladman D. Germ Line DNA Methylation Profiling Provides Novel Insights into the Parent-of-Origin Effect in Psoriatic Disease [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/germ-line-dna-methylation-profiling-provides-novel-insights-into-the-parent-of-origin-effect-in-psoriatic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/germ-line-dna-methylation-profiling-provides-novel-insights-into-the-parent-of-origin-effect-in-psoriatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology